Committed to the Health & Wellbeing of Patients with Diabetes
PREDICTION FOR DIABETES COMPLICATIONS
OPTITHERA’s direct-to-consumer genetic health risk tests for type-2 diabetes complications are making Precision Medicine a reality.
HOW IT WORKSDirect-To-Consumer Test
Collect DNA Sample
You should then discuss your results with your healthcare professional.
Depending on your personalized risk assessment, your healthcare professional will have several preventive measures to offer such as lifestyle modifications or early administration of medication to prevent or delay the onset of diabetes-related complications.
Founding President of OPTITHERA
CM, OQ, MD, PhD, FRCPC, FAHA, FRSM, FCAHS
Canada Research Chair in Predictive Genomics
Professor of Medicine, University of Montréal
OPTITHERA is a Precision Medicine company focused on the discovery and clinical application of genomic signatures predictive of susceptibility to complications and optimized therapeutic responsiveness of patients with diabetes.
In the news
Polygenic risk: What’s the score?
Researchers are improving risk prediction [NATURE]...
Polygenic risk scores predict diabetic complications and their response to therapy
Type 2 diabetes increases the risk of cardiovascular and renal complications, but early risk prediction can lead to timely intervention and better...